文献速递创伤骨科骨质疏松与代谢性骨病

骨转换标志物与男性桡骨远端骨折患者的骨密度及骨折关系:Mr F研究

Bone turnover markers as determinants of bone density and fracture in men with distal forearm fractures: the pathogenesis examined in the Mr F study.
PubMed 文献 · Osteoporos Int · 2021-05-15

本研究纳入58例低能量桡骨远端骨折男性与58例年龄匹配健康对照,比较骨转换标志物水平。骨折组PINP和βCTX显著高于对照,PINP和βCTX分别是全髋和桡骨远端aBMD的负向预测因子,SHBG、PINP和超远端桡骨aBMD组合可预测骨折。

要点

  • 男性桡骨远端骨折患者PINP和βCTX显著高于年龄匹配对照。
  • PINP负向预测全髋aBMD,βCTX负向预测桡骨远端aBMD。
  • SHBG、PINP和超远端桡骨aBMD组合是骨折的最佳预测模型。

核心结论

  • 骨折组PINP和βCTX显著高于对照组,且分别负向预测全髋和桡骨远端aBMD。
  • SHBG、PINP和超远端桡骨aBMD组合最能预测桡骨远端骨折可能性。

研究设计与样本

  • 横断面研究,纳入58例低能量桡骨远端骨折男性与58例年龄匹配健康对照。
  • 所有受试者接受桡骨、双髋和腰椎DXA扫描、生化检查及健康问卷。

主要发现

  • 骨折组PINP为39.2 ng/ml(SD 19.5),显著高于对照组的33.4 ng/ml(SD 13.1)(p<0.001)。
  • 骨折组βCTX为0.45 ng/ml(SD 0.21),显著高于对照组的0.37 ng/ml(SD 0.17)(p=0.037)。
  • 骨折组SHBG为37 nmol/L(SD 15.0),低于对照组的47.9 nmol/L(SD 19.2)(p=0.001)。
  • PINP负向预测全髋aBMD,βCTX负向预测桡骨远端aBMD,sclerostin正向预测腰椎和髋部aBMD。

关键数值与推荐

  • SHBG每增加1 nmol/L,桡骨远端骨折可能性降低5.1%。
  • 超远端桡骨aBMD每增加1 mg/cm²,骨折可能性降低1.4%。
  • PINP每增加1 ng/ml,骨折可能性增加6.1%。
  • PINP最高四分位组男性桡骨远端骨折可能性显著高于最低四分位组。

临床怎么用

  • 对低能量桡骨远端骨折男性,可检测PINP、βCTX和SHBG以评估骨转换状态和骨折风险。
  • 结合超远端桡骨aBMD与SHBG、PINP可优化骨折风险预测。

局限性

  • 横断面设计,需纵向研究确认或反驳这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The pathogenesis for low-trauma wrist fractures in men is not fully understood. This study found that these men had evidence of significantly higher bone turnover compared with control subjects. Bone turnover markers were negative predictors of bone mineral density and were a predictor of fracture. INTRODUCTION: Men with distal forearm fractures have reduced bone density, an increased risk of osteoporosis and of further fractures. The aim of this study was to investigate whether or not men with distal forearm fractures had evidence of altered bone turnover activity. METHODS: Fifty eight men with low-trauma distal forearm fracture and 58 age-matched healthy control subjects were recruited. All subjects underwent a DXA scan of the forearm, both hips, and lumbar spine, biochemical investigations, and health questionnaires. Measurements of beta crosslaps (βCTX), procollagen type I N-terminal propeptide (PINP), sclerostin, Dickkopf-1 (Dkk1), and fibroblast growth factor 23 (FGF 23) were made. RESULTS: Men with fracture had significantly higher PINP than controls at 39.2 ng/ml (SD 19.5) versus 33.4 ng/ml (SD13.1) (p<0.001). They also had significantly higher βCTX at 0.45 ng/ml (SD 0.21) versus 0.37 ng/ml (SD 0.17) (p= 0.037). Fracture subjects had significantly lower aBMD and PINP was a negative predictor of aBMD at the total hip and βCTX a negative predictor of forearm aBMD. Sclerostin was a positive predictor of aBMD at the lumbar spine and hip sites. Sex hormone binding globulin (SHBG) at 37nmol/L (SD 15.0) was lower in fracture cohort compared to 47.9 nmol/L (SD 19.2) (p=0.001) in control. Multiple regression revealed that the best model for prediction of fracture included SHBG, P1NP, and ultra-distal forearm aBMD. The likelihood of distal forearm fracture was decreased by 5.1% for each nmol/L increase in SHBH and by 1.4% for every mg/cm2 increase in ultra-distal forearm aBMD, but increased by 6.1 % for every ng/ml increase in P1NP. Men in the highest quartile of PINP had a significantly greater likelihood of distal forearm fracture than those in the lowest quartile. CONCLUSION: The fracture group had significantly higher PINP and βCTX compared with the control group, and these markers were negative predictors of aBMD at the total hip and forearm sites, respectively. Sclerostin was a positive predictor of the variance of spinal and hip aBMD. Likelihood of forearm fracture was best predicted by a combination of SHBG, PINP, and ultra-distal forearm aBMD. Findings of such cross-sectional data should be treated with caution, as longitudinal studies would be required to confirm or refute them.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Hanusch B, Prediger M, Tuck SP, et al. Bone turnover markers as determinants of bone density and fracture in men with distal forearm fractures: the pathogenesis examined in the Mr F study. Osteoporos Int. 2021. PMID: 33990874. doi:10.1007/s00198-021-06001-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。